A fragment of collagen XVIII inhibits angiogenesis;Et kollagen XVIII-fragment hemmer angiogenese

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 29, 2000, Pages 3547-3550

  Zätterström, Ulf K ^a   Fukai, Naomi ^a   Olsen, Bjørn R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN; ENDOTHELIAL CELL GROWTH FACTOR; PEPTIDE FRAGMENT;

ANIMAL; CELL CULTURE; CHEMISTRY; HUMAN; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); REVIEW; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; COLLAGEN; ENDOTHELIAL GROWTH FACTORS; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

EID: 0034736357     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966; 164: 491-502.
2. Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol 1996; : 167-90.
3. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med 1998; 49: 407-24.
4. Gospodarowicz D, Rudland P, Lindstrom J, Benirschke K. Fibroblast growth factor: its localization, purification, mode of action, and physiological significance. Adv Metab Disord 1975; 8: 301-35.
5. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296-9.
6. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
7. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1: 149-53.
8. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA Moses M et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
9. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
10. Oh SP, Kamagata Y, Muragaki Y, Timmons S, Ooshima A, Olsen BR. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc Natl Acad Sci USA 1994; 91: 4229-33.
11. Olsen BR, Ninomiya Y. Multiplexins. I: Kreis T, Vale R, red. Extracellular matrix, anchor, and adhesion proteins. Oxford: Oxford University Press, 1999: 399-401.
12. Halfter W, Dong S, Schurer B, Cole GJ. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 1998; 273: 25404-12.
13. Hohenester E, Sasaki T, Olsen BR, Timpl R. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J 1998; 17: 1656-64.
14. Hohenester E, Sasaki T, Mann K, Timpl R. Variable zinc coordination in endostatin. J Mol Biol 2000; 297: 1-6.
15. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-7.
16. Sasaki T, Fukai N, Mann K, Gohring W, Olsen BR, Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J 1998; 17: 4249-56.
17. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000; 19: 1187-94.
18. Hagedorn M, Bikfalvi A. Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit Rev Oncol Hematol 2000; 34: 89-110.
19. Olsen BR. Life without perlecan has its problems. J Cell Biol 1999; 147: 909-11.
20. Sasaki T, Larsson H, Kreuger J, Salmivirta M, Claesson-Welsh L, Lindahl U et al. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J 1999; 18: 6240-8.
21. Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 1999; 18: 4414-23.